OCUL
Ocular Therapeutix (OCUL)
$50
About Ocular Therapeutix (OCUL)
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Details
Daily high
$8.62
Daily low
$8.31
Price at open
$8.31
52 Week High
$11.78
52 Week Low
$3.76
Market cap
1.3B
Dividend yield
0.00%
Volume
1.4M
Avg. volume
895,145
P/E ratio
-6.44
Ocular Therapeutix News
Details
Daily high
$8.62
Daily low
$8.31
Price at open
$8.31
52 Week High
$11.78
52 Week Low
$3.76
Market cap
1.3B
Dividend yield
0.00%
Volume
1.4M
Avg. volume
895,145
P/E ratio
-6.44